Viridian Therapeutics, Inc. VRDN Total debt

Total debt at other companies

AmgenAMGN

$57.3B+2.0%

Vera TherapeuticsVERA

$75.03M+37.8%

PVL

Palvella TherapeuticsPVLA

$584K—

RegenxbioRGNX

$68.95M-11.3%

Zevra Therapeutics, Inc.ZVRA

$1.5M-97.6%

Shattuck Labs, Inc.STTK

$2.89M-9.5%

FAQ

What is Viridian Therapeutics, Inc.'s total debt?

Viridian Therapeutics, Inc. (VRDN) reported total debt of $114.36M in Q2 2026.

How has Viridian Therapeutics, Inc.'s total debt changed year-over-year?

Viridian Therapeutics, Inc.'s total debt increased by 395.5% year-over-year, from $23.08M to $114.36M.

What is the long-term trend for Viridian Therapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total debt has grown at a 226.2% compound annual growth rate (CAGR), from $100K to $36.96M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.